Qingfeng Pharmaceutical Group: Clinical Trials

1 trial sponsored by Qingfeng Pharmaceutical Group, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Unknown 1

Follow Qingfeng Pharmaceutical Group: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adjunctive Therapy of Andrographolid Sulfonatein Community Acquired Pneumonia
Andrographolid Sulfonate Injection (AS Injection), Cephalosporin, Azithromycin, Minocycline or Doxycycline - Community Acquired Pneumonia
Phase 4UnknownQingfeng Pharmaceutical Group4622016-07-012018-04-10

Conditions studied

Community-Acquired Pneumonia (1)

Interventions

Azithromycin (1)  ·  Cephalosporins (1)  ·  Doxycycline (1)  ·  Fluoroquinolones (1)  ·  Minocycline (1)

Countries

China (1)

Top investigators

Bin Cao, Professor (1)  ·  Bo Liu, Professor (1)  ·  Chen Wang, Professor (1)  ·  Hong Fan, Professor (1)  ·  Jie Cao, Professor (1)  ·  Jin Chen, Professor (1)  ·  Li Gu, Professor (1)  ·  Shufeng Xu, Professor (1)  ·  Wei Zhang, Professor (1)  ·  Xin Su, Professor (1)  ·  Xinri Zhang, Professor (1)  ·  Xuedong Liu, Professor (1)  ·  Yan Yi, Professor (1)  ·  Yuguang Wang, Professor (1)  ·  Yuping Li, Professor (1)

Results publications

PMID 41489779